Dechra Pharma H1 Profit Climbs, Lifts Dividend; Says Trading At H2 Start Strong - Quick Facts

Dechra Pharmaceuticals PLC (DPH.L) reported Monday that its first-half profit before taxation grew to 53.4 million pounds from last year's 35.4 million pounds. Earnings per share were 37.38 pence, up 74.3 percent from 21.44 pence a year ago.

Underlying profit before taxation was 90.5 million pounds, compared to 75.1 million pounds. Underlying earnings per share were 64.01 pence, up from 54.28 pence last year.

EBITDA grew 15 percent to 101.3 million pounds from 88.2 million pounds a year ago.

Revenue for the period grew 10.9 percent to 332.4 million pounds from last year's 299.8 million pounds. Revenues climbed 15.9 percent at constant currency rates.

Further, the Board declared an interim dividend of 12.00 pence per share, a growth of 8 percent on the prior period. The dividend will be payable on April 7 to shareholders on the Register at March 4.

Looking ahead, the company noted that trading at the start of the second half remains strong, especially in major markets which are returning to historic levels of growth as they normalise following the diminishing influence of COVID-19.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT